A Review of a Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes
Advertisement
Advertisement
Trending on AJMC
1
FDA to Remove Black Box Warnings From HRT, Debate Ensues
2
POLY-HF: Polypill Boosts Heart Function, Adherence in Heart Failure
3
Risk-Based Contracts May Not Cut Low-Value Care in Medicare Advantage
4
Tirzepatide’s Dual Approach Better for MACE, HF: Stephen Nicholls, MBBS
5
